MORE than 200,000 patients
may have ceased statin therapy
because of media reports of side
effects, leading to 2,000 extra
cardiovascular events (CVEs) within
10 years, research published in the
British Medical Journal has alerted.
Study author Liam Smeeth, of
the London School of Hygiene
and Tropical Medicine, said the
wideapread coverage of health
stories can have “important, real
world impact” on patient and
doctor behaviour.The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jul 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jul 16
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.